Search

Search Constraints

You searched for: Author/Creator Mascola, John R.

Search Results

1. A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention. Issue 1 (1st January 2021)

2. A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings. (1st May 2021)

3. A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings. (1st May 2021)

5. Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to HIV‐1. Issue 1 (January 2017)

6. Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. Issue 1 (31st December 2023)

8. Comparison of adjuvants to optimize influenza neutralizing antibody responses. Issue 42 (30th September 2019)

9. Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2. Issue 15 (23rd March 2022)